Stock

Hyundai Motor: Morgan Stanley Overweight, sees resilience against US tariffs

Investing.com– Morgan Stanley (NYSE:MS) resumed coverage of Hyundai (OTC:HYMTF) Motor (KS:005380) with a positive rating, stating that the automaker was better positioned to weather U.S. trade tariffs than most of its global peers. 

MS rated Hyundai at Overweight with a price target of 300,000 won, indicating a 37% upside from the stock’s current levels. 

The positive rating comes with Hyundai’s stock nursing a sharp decline from recent peaks. But MS analysts said most of Hyundai’s negatives were priced in with the correction.

“We see its product mix and geographical exposures providing relatively better earnings/margin protection compared to its global peers,” MS analysts wrote in a note.

MS also cited Hyundai’s recent listing of its Indian unit, Hyundai Motor India, as a catalyst for the stock.

Hyundai was nursing steep losses in recent sessions, as anticipation of increased U.S. trade tariffs under President-elect Donald Trump battered stocks with high exposure to exports. 

But Hyundai’s export exposure extends beyond the U.S., with India serving as the country’s second biggest market after South Korea. 

Hyundai is the world’s third-largest automaker by production.

This post appeared first on investing.com

You May Also Like

Economy

A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

Editor's Pick

Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

Investing

Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

Latest News

A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 balanceandcharge.com

Exit mobile version